Company Filing History:
2 out of 4,125 
1 out of 1,151 
Years Active: 2007-2013
Title: Kirk Tanner: Innovator in Pharmaceutical Research
Introduction
Kirk Tanner is a notable inventor based in Westborough, MA (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific biological pathways. With a total of 3 patents to his name, Tanner's work has the potential to impact the treatment of various proliferative disorders.
Latest Patents
One of Tanner's latest patents is titled "Heterocyclic inhibitors of c-Met and uses thereof." This invention provides compounds that serve as inhibitors of c-Met tyrosine kinase, along with pharmaceutically acceptable compositions that include these compounds. The methods outlined in this patent aim to treat various proliferative disorders effectively. Another significant patent is "Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging." This invention offers novel compositions and methods for identifying agents that influence chromosomal stability and aging processes.
Career Highlights
Throughout his career, Kirk Tanner has worked with prominent organizations such as the Wisconsin Alumni Research Foundation and Vertex Pharmaceuticals, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Tanner has had the opportunity to work alongside esteemed colleagues, including John M Denu and Alexander Aronov. These collaborations have further enriched his research and innovation efforts.
Conclusion
Kirk Tanner's contributions to pharmaceutical research through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in the treatment of various health conditions.